APA (7th ed.) Citation

DP, T., K, P., & D, G. (2008). Long-term efficacy of up to 15 months' efalizumab therapy in patients with moderate-to-severe chronic plaque psoriasis. Dermatologic therapy, 21 Suppl 3, S6. https://doi.org/10.1111/j.1529-8019.2008.00235.x

Chicago Style (17th ed.) Citation

DP, Toth, Papp K, and Gratton D. "Long-term Efficacy of Up to 15 Months' Efalizumab Therapy in Patients with Moderate-to-severe Chronic Plaque Psoriasis." Dermatologic Therapy 21 Suppl 3 (2008): S6. https://doi.org/10.1111/j.1529-8019.2008.00235.x.

MLA (9th ed.) Citation

DP, Toth, et al. "Long-term Efficacy of Up to 15 Months' Efalizumab Therapy in Patients with Moderate-to-severe Chronic Plaque Psoriasis." Dermatologic Therapy, vol. 21 Suppl 3, 2008, p. S6, https://doi.org/10.1111/j.1529-8019.2008.00235.x.